Active brain targeting of a fluorescent P-gp substrate using polymeric magnetic nanocarrier system

Nanotechnology

Volumn 23, Issue 25, 2012, Pages

  Kirthivasan, B ^a   Singh, D ^a,b   Bommana, M M ^a   Raut, S L ^c   Squillante, E ^a   Sadoqi, M ^a  

^a ST JOHN'S UNIVERSITY   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIODISTRIBUTIONS; BRAIN HOMOGENATES; EMULSION SOLVENT EVAPORATION; ENCAPSULATION EFFICIENCY; FLUORIMETRIC ANALYSIS; MAGNETIC NANOCARRIER; MAGNETIC NANOPARTICLES; METHOXY; P-GLYCOPROTEIN; POLY LACTIC ACID; POLY-LACTIDE-CO-GLYCOLIDE; RHODAMINE 123; SPRAGUE-DAWLEY RATS; TARGETED NANOPARTICLE;

EMULSIFICATION; ENCAPSULATION; FLUORESCENCE MICROSCOPY; LACTIC ACID; MAGNETIC FIELDS; NANOPARTICLES; OLEIC ACID;

POLYMERS;

DRUG CARRIER; FLUORESCENT DYE; LACTIC ACID; MACROGOL DERIVATIVE; MAGNETITE NANOPARTICLE; MONOMETHOXYPOLYETHYLENEGLYCOL POLYLACTIDE BLOCK COPOLYMER; MONOMETHOXYPOLYETHYLENEGLYCOL-POLYLACTIDE BLOCK COPOLYMER; MULTIDRUG RESISTANCE PROTEIN; OLEIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; RHODAMINE 123;

ANIMAL; ARTICLE; BRAIN; BRAIN LEVEL; CHEMISTRY; CYTOCHEMISTRY; DRUG DELIVERY SYSTEM; FLUORESCENCE MICROSCOPY; MALE; METABOLISM; RAT; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION;

ANIMALS; BRAIN; BRAIN CHEMISTRY; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FLUORESCENT DYES; HISTOCYTOCHEMISTRY; LACTIC ACID; MAGNETITE NANOPARTICLES; MALE; MICROSCOPY, FLUORESCENCE; OLEIC ACID; P-GLYCOPROTEIN; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; RATS; RATS, SPRAGUE-DAWLEY; RHODAMINE 123; TISSUE DISTRIBUTION;

EID: 84861896051     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/23/25/255102     Document Type: Article

References (44)

1. Abbott N J, Patabendige A A K, Dolman D E M, Yusof S R and Begley D J 2010 Structure and function of the blood brain barrier Neurobiol. Dis. 37 1325
2. Aliautdin R N, Kreuter J and Kharkevich D A 2003 Drug delivery to the brain with nanoparticles Eksp. Klin. Farmakol. 66 658
3. Barbu E, Molnar E, Tsibouklis J and Gorecki D C 2009 The potential for nanoparticle-based drug delivery to the brain: overcoming the bloodbrain barrier Expert Opin. Drug Deliv. 6 55365
4. Bennewitz M F and Saltzman W M 2009 Nanotechnology for delivery of drugs to the brain for epilepsy Neurotherapeutics 6 32336
5. Bhadra D, Bhadra S, Jain P and Jain N K 2002 Pegnology: a review of PEG-ylated systems Pharmazie. 57 529 (Pubitemid 34101777)
6. Bodor N, Prokai L, Wu W M, Farag H, Jonalagadda S, Kawamura M and Simpkins J 1992 A strategy for delivering peptides into the central nervous system by sequential metabolism Science 257 1698700
7. Bradbury M W 1993 The bloodbrain barrier Exp. Physiol. 78 45372
8. Brigger I, Dubernet C and Couvreur P 2002 Nanoparticles in cancer therapy and diagnosis Polymer Conjugates Cancer Therapy 54 63151 (Pubitemid 35247520)
9. Chen C J, Chin J E, Ueda K, Clark D P, Pastan I, Gottesman M M and Roninson I B 1986 Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells Cell 47 3819 (Pubitemid 17210152)
10. Cherrick G R, Stein S W, Leevy C M and Davidson C S 1960 Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction J. Clin. Investig. 39 592600
11. Cordon-Cardo C, Obrien J P, Casals D, Rittman-Grauer L, Biedler J L, Melamed M R and Bertino J R 1989 Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at bloodbrain barrier sites Proc. Natl Acad. Sci. USA 86 6958 (Pubitemid 19037807)
12. Dufort S, Sancey L, Wenk C, Josserand V and Coll J L 2010 Optical small animal imaging in the drug discovery process Biochim. Biophys. Acta (BBA) - Biomembranes 1798 226673
13. Fernandez-Carballido A, Pastoriza P, Barcia E, Montejo C and Negro S 2008 PLGA/PEG-derivative polymeric matrix for drug delivery system applications: characterization and cell viability studies Int. J. Pharm. 352 507 (Pubitemid 351273913)
14. Fox I J and Wood E H 1960 Indocyanine green: physical and physiologic properties Proc. Staff Meet. Mayo. Clin. 35 73244
15. Fromm M F 2000 P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs Int. J. Clin. Pharm. Ther. 38 6974 (Pubitemid 30077981)
16. Fujita S, Kitayama T, Mizoguchi N, Oi Y, Koshikawa N and Kobayashi M 2012 Spatiotemporal profiles of transcallosal connections in rat insular cortex revealed by in vivo optical imaging Neuroscience 206 20111
17. Haluska M and Anthony M L 2004 Osmotic bloodbrain barrier modification for the treatment of malignant brain tumors Clin. J. Oncol. Nurs. 8 2637
18. Hamoudeh M, Faraj A A, Canet-Soulas E, Bessueille F O, Léonard D and Fessi H 2007 Elaboration of PLLA-based superparamagnetic nanoparticles: characterization, magnetic behaviour study and in vitro relaxivity evaluation Int. J. Pharm. 338 24857 (Pubitemid 46783978)
19. Jain A and Jain S K 2008 PEGylation: an approach for drug delivery. A review Crit. Rev. Ther. Drug Carrier Syst. 25 40347
20. Kim H R, Gil S, Andrieux K, Nicolas V, Appel M, Chacun H, Desmaele D, Taran F, Georgin D and Couvreur P 2007 Low-density lipoprotein receptor-mediated endocytosis of PEGylated nanoparticles in rat brain endothelial cells CMLS Cell Mol. Life Sci. 64 35664
21. Kreuter J 2004 Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain J. Nanosci. Nanotechnol. 4 4848 (Pubitemid 39387399)
22. Kreuter J 2005 Application of nanoparticles for the delivery of drugs to the brain Int. Congr. Ser. 1277 8594 (Pubitemid 43693337)
23. Kroll R A and Neuwelt E A 1998 Outwitting the bloodbrain barrier for therapeutic purposes: osmotic opening and other means Neurosurgery 42 108399 (discussion 1099100) (Pubitemid 28196521)
24. Li Y P, Pei Y Y, Zhang X Y, Gu Z H, Zhou Z H, Yuan W F, Zhou J J, Zhu J H and Gao X J 2001 PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats J. Control. Release 71 20311 (Pubitemid 32234381)
25. Luan X, Skupin M, Siepmann J R and Bodmeier R 2006 Key parameters affecting the initial release (burst) and encapsulation efficiency of peptide-containing poly(lactide-co-glycolide) microparticles Int. J. Pharm. 324 16875 (Pubitemid 44528915)
26. Luo S, Zhang E, Su Y, Cheng T and Shi C 2011 A review of NIR dyes in cancer targeting and imaging Biomaterials 32 712738
27. Mamot C et al 2004 Extensive distribution of liposomes in rodent brains and brain tumors following convection-enhanced delivery J. Neurooncol. 68 19 (Pubitemid 39137344)
28. Namane A, Gouyette C, Fillion M P, Fillion G and Huynh-Dinh T 1992 Improved brain delivery of AZT using a glycosyl phosphotriester prodrug J. Med. Chem. 35 303944
29. Okassa L N, Marchais H, Douziech-Eyrolles L, Hervé K, Cohen-Jonathan S, Munnier E, Soucé M, Linassier C, Dubois P and Chourpa I 2007 Optimization of iron oxide nanoparticles encapsulation within poly(d,l-lactide-co-glycolide) sub-micron particles Eur. J. Pharm. Biopharm. 67 318 (Pubitemid 46991326)
30. Pardridge W M 2005 The bloodbrain barrier: bottleneck in brain drug development NeuroRx 2 314 (Pubitemid 40128022)
31. Parikh T, Bommana M M and Squillante E 2010 Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain Eur. J. Pharm. Biopharm. 74 44250
32. Petri B, Bootz A, Khalansky A, Hekmatara T, Muller R, Uhl R, Kreuter J and Gelperina S 2007 Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants J. Control. Release 117 518 (Pubitemid 46164866)
33. Prencipe G, Tabakman S M, Welsher K, Liu Z, Goodwin A P, Zhang L, Henry J and Dai H 2009 PEG branched polymer for functionalization of nanomaterials with ultralong blood circulation J. Am. Chem. Soc. 131 47837
34. Prokai-Tatrai K and Prokai L 2011 Prodrug design for brain delivery of small- and medium-sized neuropeptides Methods Mol. Biol. 789 31336
35. Qin Y et al 2010 In vitro and in vivo investigation of glucose-mediated brain-targeting liposomes J. Drug Targeting 18 53649
36. Raut S L, Kirthivasan B, Bommana M M, Squillante E and Sadoqi M 2010 The formulation, characterization and in vivo evaluation of a magnetic carrier for brain delivery of NIR dye Nanotechnology 21 395102
37. Reimold I, Domke D, Bender J, Seyfried C A, Radunz H E and Fricker G 2008 Delivery of nanoparticles to the brain detected by fluorescence microscopy Eur. J. Pharmaceut. Biopharmaceut. 70 62732 (official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V)
38. Safa A R, Glover C J, Sewell J L, Meyers M B, Biedler J L and Felsted R L 1987 Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blockers J. Biol. Chem. 262 78848 (Pubitemid 17103907)
39. Shek C H, Shao Y Z and Lai J K L 2000 Transition from superparamagnetism to ferromagnetic single-domain in a Heisenberg model for nano-cluster magnetic system Physica A 276 20114 (Pubitemid 30536716)
40. Te Velde E A, Veerman T, Subramaniam V and Ruers T 2010 The use of fluorescent dyes and probes in surgical oncology Eur. J. Surg. Oncol. (EJSO) 36 615
41. Troutman M D and Thakker D R 2003 Rhodamine 123 requires carrier-mediated influx for its activity as a P-glycoprotein substrate in Caco-2 cells Pharm. Res. 20 11929 (Pubitemid 36951844)
42. Visser C C, Stevanovic S, Voorwinden L H, Van Bloois L, Gaillard P J, Danhof M, Crommelin D J and De Boer A G 2005 Targeting liposomes with protein drugs to the bloodbrain barrier in vitro Eur. J. Pharm. Sci. 25 299305 (Pubitemid 40725060)
43. Zhang L, He R and Gu H C 2006 Oleic acid coating on the monodisperse magnetite nanoparticles Appl. Surf. Sci. 253 26117 (Pubitemid 44820534)
44. Zhao H et al 2010 A comparative study of transfection efficiency between liposomes, immunoliposomes and brain-specific immunoliposomes J. Int. Med. Res. 38 95766